What do you really know about Medicaid? Take our quiz and find out.
What do you really know about Medicaid? Take our quiz and find out.
Medicaid will be at the center of talks this week on Capitol Hill as House Republicans consider how to cut a program that is the primary source of health insurance coverage for low-income populations. Paid for by the federal government and states (as well as D.C.), Medicaid is a lifeline for many groups, including children and seniors.
Members of the Energy and Commerce Committee, which has jurisdiction over health care, are charged with finding $880 billion in savings, which they can't do without touching Medicaid. Yet some lawmakers say they won't vote for a bill that scales back a program on which many of their constituents rely.
How much do you know about how Medicaid works? Test your knowledge with our quiz:
Story continues below advertisement
Advertisement
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Healthcare companies chase cures and capital in South Florida
Leaders of hundreds of public healthcare companies are in South Florida this week, talking up their innovations and financial performances to attract and impress investors at the Goldman Sachs Global Healthcare Conference. Consumers will find that nearly every disease or ailment they suffer from has a treatment in development, as big and small companies see opportunities in Americans' desire to live longer and pain-free. From new devices for sleep apnea to drugs for cancer, to creams for chronic itching and drops for improved eyesight, advances are underway that hold promise. Presenters like LENZ Therapeutics wowed the audience on Monday with product updates, such as an eyedrop that lasts all day and allows for close-up vision, which most people use reader glasses to achieve. The eye drops target a market of over 128 million people in the U.S. who need help with near vision. This year, new factors are affecting how quickly consumers can obtain a drug or device to improve or save their lives, according to company executives. The uncertainty in Washington, D.C., looms large. Policy turbulence, regulatory uncertainty, shakeups at health agencies and President Donald Trump's aggressive stance on drug pricing and tariffs factor into the future for the devices and treatments working their way toward the marketplace. Anti-Trump protests will unfold across South Florida this weekend. Here's what to expect Top RFK Jr. aide attacks US health system while running company that promotes wellness alternatives Hidden charges? Patients often face massive bills when Florida hospitals don't provide costs upfront Native Americans hurt by federal health cuts, despite RFK Jr.'s promises of protection Georgia's experience raises red flags for Medicaid work requirement moving through Congress 'This year, the biggest questions we are opening with for all of our companies is the policy calculus in Washington, D.C., and how that could play out across the healthcare sector,' said Asad Haider, Goldman Sachs' head of the healthcare business unit within Global Investment Research and the lead analyst for the U.S. pharmaceuticals sector. 'The starting point in all these presentations is give us the landscape on where things could go with respect to what's going on in Washington, D.C.' Over 200 top managerial teams attended the conference, representing every corner of the healthcare field, from major pharmaceutical companies to small biotech firms. The goal of the three-day conference was to provide institutional investors with insights into companies' business plans, data, and progress, particularly at a strategic mid-year point. Innovation hotspots this year include treatments for weight loss, with a focus on oral drugs replacing injectables and medications to help maintain a healthy weight. Another is oncology, immunology, and neuroscience with breakthroughs to detect diseases earlier and find new drug delivery methods. Several companies at the conference have formed partnerships with companies across the globe to access new markets, technologies, and expertise. China is emerging as a global leader in biotechnology, with numerous U.S. and European companies collaborating with or licensing technologies from Chinese companies. Summit Therapeutics, a Miami-based company, drew interest at the conference with its innovative cancer-fighting, bispecific antibody, ivonescimab, and its partnership with a Chinese laboratory. Ivonescimab has shown promise in previous trials in China and additional trials are underway combining the drug with chemotherapy to target non-small-cell lung cancer. 'We have over 22 or 23 different trials going on or completed or going to start,' said Maky Zangaheh, co-CEO of Summit Therapeutics. 'One element of that is a phase 3 trial that China and us are combining with over 3,000 patients enrolled, so we will have a good safety profile and efficacy profile in many different therapeutic areas. From a commercialization point of view, we are already in China and have two Chinese approvals, which is significant progress.' Doron Junger, of Sanvia Capital, a South Florida biotech investment firm, said he attended the conference looking to invest in companies developing innovations that could address large or niche markets in a more meaningful way. A few have caught his attention; however, he is cautious about those who tout therapies in their pipelines. 'More drug trials fail than succeed, and while there is a lot of innovation in this industry in areas of need like oncology and chronic diseases, even at a late stage, there is potential for a clinical trial to fail to show an advantage over a placebo group,' he said. 'Even if it does, that trial has to pass muster with the rigorous standards the FDA sets for approval.' On Monday, Arcturus Therapeutics of San Diego presented an update on a daily inhaled treatment for Cystic Fibrosis, which could be a breakthrough for the disease. Additionally, BioAge Labs CEO Kristen Fortney explained how her California company uses samples from a repository to study the biology of human aging and develop new therapies for obesity. Even after scrapping its lead obesity candidate due to liver toxicity, BioAge Labs is not shying away from the weight loss space and believes it can improve upon oral therapies now on the market, she said. 'More and more people are aging, and by definition, they are using more healthcare,' said Haider of Goldman Sachs. 'The aging population is going to need new drugs, better drugs, faster drugs for diabetes and cardiometabolics and oncology and all of these diseases that potentially could kill you. There will be innovation, but what are we willing to pay for that innovation?' Will regulations make it more difficult and/or costly for people to access the devices and drugs that can save their lives? Haider said drug pricing will be a key concern for both consumers and investors. 'Everyone is chasing big caps, big targets, but there will be winners and losers.' South Florida Sun Sentinel health reporter Cindy Goodman can be reached at cgoodman@
Miami Herald
an hour ago
- Miami Herald
Nearly 700,000 Americans Lose Health Care Coverage in 2025
Almost 700,000 Americans lost Medicaid coverage in one month at the start of this year, according to new enrollment data compiled by KFF. The significant drop in Medicaid enrollment in January from December 2024 is part of a long-term trend amid the continuation of the federal program's "unwinding" process, which began after pandemic-era protections ended. Enrollment was still higher in January than it was in February 2020. The data highlights the continued ripple effects of the Medicaid policy shift, with millions more likely to be affected in the months ahead-particularly low-income families, children, and older adults who rely on Medicaid for basic care access. Health care experts and advocates warn that the unwinding process is opening large gaps in the U.S. health care system, with many falling through the cracks due to administrative barriers or lack of communication, not because they no longer qualify. Data collected by KFF shows that from December 2024 to January 2025, Medicaid enrollment dropped by 669,938, bringing the total number of Americans enrolled in Medicaid to around 71.2 million. While this number remains high, it reflects a steady monthly decline that began in 2023 when states resumed redeterminations, where they checked whether enrollees were still eligible for benefits. The process had been paused during the COVID-19 public health emergency alongside an expansion to the federal protection available for vulnerable Americans with limited income and resources. When those protections were lifted following the pandemic, millions faced the risk of being disenrolled-not just due to income changes, but because of paperwork errors, missed deadlines, or outdated contact information. According to KFF's data, more than 16 million people have been disenrolled from Medicaid since the unwinding began in the spring of 2023. An April 2024 survey by KFF of 1,227 U.S. adults who had Medicaid coverage in prior to April 1, 2023, found that 28 percent of former enrolees found other forms of health coverage, while 47 percent were eventually re-enrolled to Medicaid. Around a quarter of enrolees reported as remaining uninsured. States like Montana, Tennessee and Colorado have seen some of the largest decreases in enrollment, with levels in January 2025 dropping below pre-pandemic levels. William Schpero, assistant professor of population health sciences at Weill Cornell Medicine, told Newsweek: "This is evidence that we are likely still seeing the effects of the end of the continuous coverage provisions in place during the COVID-19 Public Health Emergency that paused redeterminations of Medicaid eligibility. During the 'unwinding' of continuous coverage through September 2024, close to 70 percent of those who lost coverage were disenrolled for purely procedural reasons-for example, they missed a required renewal form because of a change in address. Many of these people likely remained eligible for Medicaid." He added: "It would be particularly concerning if procedural terminations continue to underlie the latest reported decreases in Medicaid enrollment. It suggests that states can be doing more to prevent avoidable losses of coverage. Research has estimated that a large portion of individuals who have lost Medicaid in recent months have become uninsured or experienced gaps in coverage. We have consistent evidence that loss of Medicaid coverage interrupts access to care - without coverage, people forgo visiting the doctor or taking their prescribed medications due to cost. Ultimately this will hurt health outcomes." Kathleen Adams, professor of health policy and management at Emory University's Rollins School of Public Health, Georgia, told Newsweek: "We are always concerned with the loss of insurance coverage, especially among the lower income and vulnerable groups traditionally served by Medicaid. If these individuals are not able to find a source of other coverage such as Employer Sponsored Insurance (ESI) or through the subsidized exchanges, they will have lower access to needed health care, face higher costs if they obtain care and could impose costs on the health care system as they are forced to seek care in ERs or other publicly subsidized sources of care." She added: "The unwinding has taken place over a year and as the report notes, Medicaid enrollment is still higher now than in the pre-pandemic period. It is also important to note the differences seen across states. Some states that had not expanded Medicaid under the ACA did so recently and many of them show the largest increases in enrollment from their pre-pandemic levels. Currently, the concerns with Medicaid enrollment are with the administration's proposed changes to Medicaid eligibility which some states are already seeking to implement." Unless policies change, experts project that millions more Americans may lose health coverage through 2025, not just due to changes in eligibility requirements, but also because of bureaucratic hurdles. Related Articles VA Marks Benefits Milestone For VeteransCan Tackling Addictions Reduce Medicaid Costs?Most Republicans Enrolled in Medicaid 'Worried' About Funding Cuts-PollAmerican's Trip to Italy Leads to Shocking Revelation About US: 'So Much Resentment' 2025 NEWSWEEK DIGITAL LLC.
Miami Herald
an hour ago
- Miami Herald
Map Shows States Where People Are Being Removed From Health Care Plan
Nearly every U.S. state has seen a drop in Medicaid enrollment since the spring of 2023, when COVID-era health care provisions were first rolled back. Only North Carolina has seen an increase in enrollment between March 2023 and January 2025, while South Dakota's Medicaid enrollment levels on average have remained the same. After federal health care provisions were expanded during the COVID pandemic, Medicaid enrollees have since been continuously pushed off the program as part of the "unwinding" process to roll back pandemic-era provisions. During the three years of the pandemic, states paused Medicaid disenrollment, but after March 2023, they each re-started the process of overseeing and reviewing enrollees' eligibility for the program, meaning many have lost their health care coverage. This could be due to a change in income but also because of paperwork errors, missed deadlines, or outdated contact information. Health experts have warned about the impact the unwinding process can have on America's most vulnerable populations, such as worsening health outcomes, increasing costs in emergency care and many other issues. States' decline in Medicaid enrollment between March 2023 and January 2025 has been happening at varying rates. Montana was the state with the sharpest drop, with Medicaid enrollment shrinking by 37 percent between March 2023 and January 2025. Texas, Colorado and Utah were other states that saw Medicaid enrollment rates drop by more than 30 percent in the same time period. California and Oregon saw much less significant changes to Medicaid coverage - seeing drops of less than 10 percent each. While most states have seen a decrease in enrollment since the spring of 2023, overall, many have not yet had Medicaid enrollment rates return to pre-pandemic levels. The unwinding process has resulted in millions of Americans losing their Medicaid coverage across the country-a total of around 16 million between March 2023 and January 2025. Paul Shafer, a professor in health law, policy and management at Boston University, told Newsweek: "Nearly all states had already completed their unwinding by the end of 2024 so continued declines are concerning, especially when accelerating relative to months prior. Data on the uninsured rate hasn't quite caught up, bouncing between 7.7 and 8.5 percent from mid-2023 to September 2024. ACA Marketplace enrollment was up nearly 3 million for 2025 versus 2024 so some of those losing Medicaid are finding other coverage, but we know that many likely aren't. However, these coverage losses are only the beginning if the Medicaid cuts proposed in the One Big Beautiful Bill Act are passed. We would expect to see 7 to 11 million more Americans lose Medicaid and more hospital closures, particularly in rural areas." He added: "Losing health insurance coverage can have both short and long-term impacts, from delayed care to not refilling prescriptions to later diagnoses of cancer and higher mortality rates-none of which we want to see. The underlying health needs won't go away and in fact will get worse if untreated, so we are risking a continued decline in life expectancy and further increasing the divide between have and have-nots when it comes to health. Safety net and rural hospitals also rely more on Medicaid payments than others, and if they close, everyone suffers, not just those on Medicaid." With new policies still being finalized and debated in Congress, changes to the Medicaid program and eligibility are expected to result in further disenrollment-with the Congressional Budget Office predicting more than 13 million Americans could lose their Medicaid coverage by 2034. Related Articles Nearly 700,000 Americans Lose Health Care Coverage in 2025Nurses Were Covid Heroes. Now They're Being Squeezed by Medicaid CutsCan Tackling Addictions Reduce Medicaid Costs?Most Republicans Enrolled in Medicaid 'Worried' About Funding Cuts-Poll 2025 NEWSWEEK DIGITAL LLC.
